LPL Financial
MCRB icon

LPL Financial’s Seres Therapeutics MCRB Stock Holding History

LPL Financial’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,757
Closed -$66.6K – 5642
2025
Q1 		$66.6K Buy
4,757
+18
+0.4% +$282 ﹤0.01% 5113
2024
Q4 		$78.8K Sell
4,739
-1,372
-22% -$22.3K ﹤0.01% 5037
2024
Q3 		$116K Sell
6,111
-920
-13% -$18.7K ﹤0.01% 4867
2024
Q2 		$102K Buy
7,031
+542
+8% +$9.04K ﹤0.01% 4741
2024
Q1 		$100K Buy
6,489
+712
+12% +$15.4K ﹤0.01% 4680
2023
Q4 		$162K Sell
5,777
-421
-7% -$11.1K ﹤0.01% 4447
2023
Q3 		$295K Buy
6,198
+445
+8% +$34K ﹤0.01% 3937
2023
Q2 		$551K Buy
5,753
+969
+20% +$105K ﹤0.01% 3355
2023
Q1 		$542K Buy
4,784
+139
+3% +$15K ﹤0.01% 3253
2022
Q4 		$520K Sell
4,645
-410
-8% -$55K ﹤0.01% 3215
2022
Q3 		$649K Sell
5,055
-105
-2% -$10.8K ﹤0.01% 2913
2022
Q2 		$354K Buy
5,160
+2,655
+106% +$229K ﹤0.01% 3489
2022
Q1 		$357K Buy
2,505
+210
+9% +$32.3K ﹤0.01% 3444
2021
Q4 		$382K Buy
2,295
+194
+9% +$30.8K ﹤0.01% 3510
2021
Q3 		$292K Sell
2,101
-1,134
-35% -$222K ﹤0.01% 3677
2021
Q2 		$1.54M Sell
3,235
-8
-0.2% -$3.38K ﹤0.01% 2191
2021
Q1 		$1.34M Buy
3,243
+345
+12% +$159K ﹤0.01% 2151
2020
Q4 		$1.42M Sell
2,898
-57
-2% -$33.4K ﹤0.01% 1922
2020
Q3 		$1.67M Sell
2,955
-771
-21% -$256K ﹤0.01% 1561
2020
Q2 		$355K Sell
3,726
-90
-2% -$7.9K ﹤0.01% 2702
2020
Q1 		$272K Buy
3,816
+543
+17% +$36.4K ﹤0.01% 2570
2019
Q4 		$226K Buy
3,273
+135
+4% +$10K ﹤0.01% 3005
2019
Q3 		$252K Buy
3,138
+483
+18% +$31.9K ﹤0.01% 2822
2019
Q2 		$171K Buy
2,655
+1,987
+297% +$189K ﹤0.01% 3066
2019
Q1 		$92K Buy
+668
New +$81.4K ﹤0.01% 3078

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

LPL Financial's MCRB Position: Q2 2025 in Review

LPL Financial sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 4,757 shares — an estimated $66.6K sold.

LPL Financial first reported a position in MCRB in Q1 2019 and held it in 25 quarters. The position peaked at $1.67M in Q3 2020. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.

  • LPL Financial reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
  • LPL Financial sold 4,757 Seres Therapeutics shares in Q2 2025, an estimated $66.6K.
  • LPL Financial first reported a position in Seres Therapeutics in Q1 2019 and held it in 25 quarters.
  • LPL Financial's Seres Therapeutics position peaked at $1.67M in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.

Based on LPL Financial's 13F filing for Q2 2025, filed 12 Aug 2025.